Xencor | XNCR - EPS Earnings Per Share


Xencor reported $-0.09 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -0.66 -0.66 May/13 2026
FY2025Q4 Dec/2025 -0.09 -0.6 -0.62 Feb/25 2026
FY2025Q3 Sep/2025 -0.08 -0.69 -0.71 Nov/05 2025
FY2025Q2 Jun/2025 -0.41 -0.65 -1.07 Aug/06 2025
FY2025Q1 Mar/2025 -0.66 -0.80 -1.11 May/07 2025




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Cytokinetics USD -1.5 1.05 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
J&J USD 2.46 0.34 Dec/2025
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 0.27 0.84 Sep/2025
Merck USD 2.04 0.54 Dec/2025
Novartis USD 2.04 0.38 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Xencor USD -0.09 0.01 Dec/2025